166 related articles for article (PubMed ID: 25459665)
1. Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.
Tognela A; Spring KJ; Becker T; Caixeiro NJ; Bray VJ; Yip PY; Chua W; Lim SH; de Souza P
Crit Rev Oncol Hematol; 2015 Feb; 93(2):90-102. PubMed ID: 25459665
[TBL] [Abstract][Full Text] [Related]
2. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
[TBL] [Abstract][Full Text] [Related]
3. CTC-Race: Single-Cell Motility Assay of Circulating Tumor Cells from Metastatic Lung Cancer Patients.
Liu Y; Zhao W; Hodgson J; Egan M; Cooper Pope CN; Hicks G; Nikolinakos PG; Mao L
ACS Nano; 2024 Mar; 18(12):8683-8693. PubMed ID: 38465942
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer.
Ke H; Kao S; van Zandwijk N; Rasko JEJ; Yeo D
Lung Cancer; 2024 Jun; 192():107829. PubMed ID: 38810528
[TBL] [Abstract][Full Text] [Related]
5. Can microRNAs improve the management of lung cancer patients? A clinician's perspective.
Tufman A; Tian F; Huber RM
Theranostics; 2013 Dec; 3(12):953-63. PubMed ID: 24396506
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in Early Diagnosis and Early Stage Lung Cancer: The Clinician's Point of View.
Gasparri R; Sedda G; Spaggiari L
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32526831
[TBL] [Abstract][Full Text] [Related]
7. Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?
Ilie M; Hofman V; Long E; Bordone O; Selva E; Washetine K; Marquette CH; Hofman P
Ann Transl Med; 2014 Nov; 2(11):107. PubMed ID: 25489581
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells in lung cancer: detection methods and clinical applications.
Yu N; Zhou J; Cui F; Tang X
Lung; 2015 Apr; 193(2):157-71. PubMed ID: 25690734
[TBL] [Abstract][Full Text] [Related]
9. CTC enumeration and characterization: moving toward personalized medicine.
Toss A; Mu Z; Fernandez S; Cristofanilli M
Ann Transl Med; 2014 Nov; 2(11):108. PubMed ID: 25489582
[TBL] [Abstract][Full Text] [Related]
10. Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment.
Nel I; Jehn U; Gauler T; Hoffmann AC
Transl Lung Cancer Res; 2014 Apr; 3(2):100-6. PubMed ID: 25806288
[TBL] [Abstract][Full Text] [Related]
11. The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells.
Gazzaniga P; Raimondi C; Nicolazzo C; Carletti R; di Gioia C; Gradilone A; Cortesi E
Expert Rev Mol Diagn; 2015; 15(7):925-32. PubMed ID: 25959553
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer.
Onstenk W; Sieuwerts AM; Weekhout M; Mostert B; Reijm EA; van Deurzen CH; Bolt-de Vries JB; Peeters DJ; Hamberg P; Seynaeve C; Jager A; de Jongh FE; Smid M; Dirix LY; Kehrer DF; van Galen A; Ramirez-Moreno R; Kraan J; Van M; Gratama JW; Martens JW; Foekens JA; Sleijfer S
Cancer Lett; 2015 Jun; 362(1):36-44. PubMed ID: 25797316
[TBL] [Abstract][Full Text] [Related]
13. Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions.
Zhang Z; Ramnath N; Nagrath S
Front Oncol; 2015; 5():209. PubMed ID: 26484313
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
15. Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies?
Dawood S; Cristofanilli M
Pharmacogenomics; 2015; 16(7):669-72. PubMed ID: 25950463
[No Abstract] [Full Text] [Related]
16. Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients.
Mostert B; Sieuwerts AM; Kraan J; Bolt-de Vries J; van der Spoel P; van Galen A; Peeters DJ; Dirix LY; Seynaeve CM; Jager A; de Jongh FE; Hamberg P; Stouthard JM; Kehrer DF; Look MP; Smid M; Gratama JW; Foekens JA; Martens JW; Sleijfer S
Ann Oncol; 2015 Mar; 26(3):510-6. PubMed ID: 25471333
[TBL] [Abstract][Full Text] [Related]
17. Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer.
Hanssen A; Loges S; Pantel K; Wikman H
Front Oncol; 2015; 5():207. PubMed ID: 26442219
[TBL] [Abstract][Full Text] [Related]
18. Quantification of concentration and assessment of EGFR mutation in circulating DNA.
Mazurek A; Pierzyna M; Giglok M; Dworzecka U; Suwiński R; Ma Usecka E
Cancer Biomark; 2015; 15(4):515-24. PubMed ID: 25769456
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity.
McInnes LM; Jacobson N; Redfern A; Dowling A; Thompson EW; Saunders CM
Front Oncol; 2015; 5():42. PubMed ID: 25767772
[TBL] [Abstract][Full Text] [Related]
20. Importance of circulating tumor cells in newly diagnosed colorectal cancer.
van Dalum G; Stam GJ; Scholten LF; Mastboom WJ; Vermes I; Tibbe AG; De Groot MR; Terstappen LW
Int J Oncol; 2015 Mar; 46(3):1361-8. PubMed ID: 25572133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
